City

Philadelphia (1)

San Francisco (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Phase

n/a (1)

phase 2 (1)

Sponsor

ECOG-ACRIN Cancer Research Group (1)

University of California, San Francisco (1)

Collaborator

National Cancer Institute (NCI) (1)

Varian Medical Systems (1)

Intervention

capecitabine (1)

carboplatin (1)

cisplatin (1)

fluorouracil (1)

laboratory biomarker analysis (1)

paclitaxel (1)

quality-of-life assessment (1)

radiation therapy (rt) (1)

Study Documents

Intervention Type

drug (1)

other (1)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (2)

metastatic anal canal carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Squamous Cell Carcinoma Trial in Philadelphia (Capecitabine,

Active, not recruiting

Anal Basaloid Carcinoma
+6 more

Capecitabine
+6 more

Philadelphia, Pennsylvania

ECOG-ACRIN Cancer Research Group

Jan 3, 2023

Stage IV Esophageal Adenocarcinoma, Stage IV Esophageal Squamous Cell Carcinoma, Stage IV Gastric Cancer Trial in San Francisco

Recruiting

Stage IV Esophageal Adenocarcinoma
+43 more

Radiation Therapy (RT)

San Francisco, California

University of California, San Francisco

Mar 29, 2022